My Account | Shopping Cart | Contact
Trilink Biotech Logo

Oligonucleotides | mRNA & Long RNA | Nucleotides | CleanCap™ | CleanTag™ | CleanAmp™ | Custom Chemistry | GMP


Richard Hogrefe

Rick Hogrefe Ph.D., is the President and Chief Executive Officer of TriLink BioTechnologies. Rick, a serial entrepreneur, cofounded TriLink in 1996 after identifying the market need for high quality modified oligonucleotides and nucleic acid triphosphates. Prior to TriLink, Rick was a founder of Glen Research, Glen Midland Certified Reagent, and Solulink. Over the past 20 years, Rick’s leadership and vision has enabled TriLink to steadily grow by providing customers with innovative products and an exceptional level of service and support. Rick earned his Ph.D. with Professor Robert L. Letsinger at Northwestern University focusing on modified nucleic acids and oligonucleotide trihaloethyl phosphotriesters. In 2016 Rick led the sale and transition of TriLink to Maravai Life Sciences securing the future growth and stability of TriLink.

Terry Beck

Terry Beck is the Senior Vice President of Operations. Terry received his Bachelor of Science degree in Biochemistry and Cell Biology from the University of California, San Diego. Terry joined Gen-Probe and was part of the research team on the forefront of developing new DNA diagnostic technology for the detection of tuberculosis, AIDS, STDs, and cancer. Prior to cofounding TriLink, Terry was a research scientist at Genta developing antisense oligotherapeutic compounds targeting lymphoma. For over 20 years Terry has been responsible for the growth and expansion of TriLink’s manufacturing capabilities, the development of a world class customer support and service team, and commercial strategic planning.

David Combs

David Combs, Ph.D., is the Vice President of Operations. Dave joined TriLink in 2000 as the Head of Chemistry Manufacturing after completing his postdoctoral research at San Diego State University focused on the synthesis of inorganic/organometallic catalysts to capture and functionalize ketenes. In 2015 Dave became the Sr Director of Manufacturing responsible for product tech transfer from R&D, process development, process optimization, production, and manufacturing continuous improvement programs. In his current role, Dave oversees all operations within manufacturing across the entire TriLink product portfolio including custom and OEM chemistry, nucleic acid monomers, oligonucleotides, mRNA, GMP diagnostics, and GMP API production.

Craig Dobbs

Craig Dobbs is the Vice President of Marketing and Sales. Craig has 25 years of diverse commercial experience in the Life Science market defining, developing, and delivering disruptive technologies into discovery research, process development, manufacturing, and QA/QC. Prior to joining TriLink in 2015 Craig was responsible for developing the process analytics market at Waters Corp. He has served in a variety of senior commercial roles with Biosearch (Millipore), Applied Biosystems (Danaher), and Pharmacia Biotech (GE Healthcare). Craig is a graduate of Trinity College and trained in synthetic biochemistry with Emil T. Kaiser at the Rockefeller University and Michael E. Selsted at the University of California, Irvine.

Anton McCaffrey

Anton McCaffrey, Ph.D., is the Senior Director of Research and Development. Anton has over 25 years of experience designing nucleic acid based therapeutics for antisense, RNA interference, aptamer, and genome editing applications. Prior to joining TriLink in 2011, Anton was an Assistant Professor at the University of Iowa where his team focused on the role of microRNAs during the pathogenesis of hepatitis C and zinc-finger nuclease based therapeutics for treatment of hepatitis B. Anton leads TriLink’s R&D team developing novel chemical modifications of mRNA to reduce innate immune stimulation, optimized and scalable mRNA manufacturing processes, and specialized assays for mRNA characterization. Anton received his Ph.D. from the University of Colorado, Boulder in the laboratory of Professor Olke Uhlenbeck and completed his Postdoctoral Fellowship at Stanford University with Professor Mark Kay where he contributed to pioneering work in the field of RNA interference.